(Q44565700)

4 December 2017

title

Might losartan reduce sudden cardiac death in diabetic patients with hypertension? (English)

1 reference

4 December 2017

1 reference

1

Wilbert S Aronow

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

4 December 2017

1 reference

4 December 2017

volume

362

1 reference

4 December 2017

issue

9384

1 reference

4 December 2017

page(s)

591-592

1 reference

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914208-0

7 January 2021

A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914208-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914208-0

7 January 2021

Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914208-0

7 January 2021

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914208-0

7 January 2021

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914208-0

7 January 2021

Beta-blocker therapy in the cardiac arrhythmia suppression trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914208-0

7 January 2021

Effect of propranolol versus no antiarrhythmic drug on sudden cardiac death, total cardiac death, and total death in patients > or = 62 years of age with heart disease, complex ventricular arrhythmias, and left ventricular ejection fraction > or = 4

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914208-0

7 January 2021

Decrease in mortality by propranolol in patients with heart disease and complex ventricular arrhythmias is more an anti-ischemic than an antiarrhythmic effect

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914208-0

7 January 2021

Circadian variation of sudden cardiac death or fatal myocardial infarction is abolished by propranolol in patients with heart disease and complex ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914208-0

7 January 2021

Primary prevention of sudden cardiovascular death in hypertensive patients. Mortality results from the MAPHY Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914208-0

7 January 2021

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914208-0

7 January 2021

Randomised trial of treatment of hypertension in elderly patients in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914208-0

7 January 2021

Hypertension and sudden death. Increased ventricular ectopic activity in left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914208-0

7 January 2021

Usefulness of echocardiographic left ventricular hypertrophy, ventricular tachycardia and complex ventricular arrhythmias in predicting ventricular fibrillation or sudden cardiac death in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914208-0

7 January 2021

Association of left ventricular hypertrophy and chronic atrial fibrillation with the incidence of new thromboembolic stroke in 2,384 older persons

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914208-0

7 January 2021

Impact of atrial fibrillation on the risk of death: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914208-0

7 January 2021

Correlation of atrial fibrillation, paroxysmal supraventricular tachycardia, and sinus rhythm with incidences of new coronary events in 1,359 patients, mean age 81 years, with heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914208-0

7 January 2021

10.1016/S0140-6736(03)14208-0

Identifiers

DOI

1 reference

4 December 2017

1 reference